Lucía Gabriela García-Lara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucía Gabriela García-Lara has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Morales-Martínez
Instituto de Ciencias Físicas, Universidad Nacional Autónoma de México (UNAM)
1 shared publication - Carina Weissmann
IFIBYNE-UBA-CONICET Buenos Aires, Buenos Aires, Argentina
1 shared publication - Cesar Augusto Rodríguez-Balderas
Departamento de Bioterio. Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, 14269, México
1 shared publication Daniel Deyoung
Department of Biochemistry, National High Magnetic Field Laboratory, Gainesville, FL, USA
1 shared publication- Francisca Pérez-Severiano
Laboratorio de Neurofarmacología Molecular y Nanotecnología, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, CDMX, México
1 shared publication - Hilda Pedraza-Espitia
Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, 14269, Insurgentes Sur #3877. Col. La Fama. Del. Tlalpan, C.P. 14269 Ciudad de México
1 shared publication
Latest Publications
- 1 June 2021
- Published by Elsevier in Neurobiology of Aging
- Vol. 102, 32-49
Evaluation of early microstructural changes in the R6/1 mouse model of Huntington's disease by ultra-high field diffusion MR imaging
- 1 June 2021
- Published by Elsevier in Neurobiology of Aging
- Vol. 102, 32-49
Evaluation of early microstructural changes in the R6/1 mouse model of Huntington's disease by ultra-high field diffusion MR imaging
- Open Access
- 26 January 2018
- Published by Universidad Nacional Autonoma de Mexico in Veterinaria México OA
- Vol. 5 (1)
Establishment and maintenance of an R6/1 transgenic mouse colony and validation of its progressive neurological phenotype to study Huntington’s disease
Huntington’s disease (HD) is a hereditary neurodegenerative disorder of the central nervous system that mainly affects the basal ganglia and has no cure. The mutation is located at an abnormal expansion of the CAG triplet in the Huntingtin gene. Humans show psychiatric, behavioural and motor disorders. Transgenic animal models are essential to the study of HD since the disease only affects humans. Therefore, the aim of this article was to describe the formation and maintenance of and to validate the progressive neurological phenotype of an R6/1 transgenic mouse colony. To achieve our objective, the colony founder was imported from Jackson Laboratories, and the mice were kept under controlled environmental conditions. The animals were bred at the vivarium of the Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. The R6/1 transgenic mice were successfully bred and showed genetic and phenotypic characteristics similar to the ones previously reported. Our colony is currently established and validated with the conditions of our vivarium and has produced more than four generations of R6/1 mice. The establishment of the R6/1 colony and its maintenance through generation is an advantage since it allows us to follow the authenticity of the transgenic mice regarding their phenotypic and motor behaviours. Furthermore, these animals can be compared with other transgenic mice that reproduce some of the main characteristics of the disease manifested in humans, making these transgenic R6/1 mice a useful tool for the study of HD.
- 26 January 2018
- Published by Universidad Nacional Autonoma de Mexico in Veterinaria México OA
- Vol. 5 (1)
Open AccessEstablishment and maintenance of an R6/1 transgenic mouse colony and validation of its progressive neurological phenotype to study Huntington’s disease
Huntington’s disease (HD) is a hereditary neurodegenerative disorder of the central nervous system that mainly affects the basal ganglia and has no cure. The mutation is located at an abnormal expansion of the CAG triplet in the Huntingtin gene. Humans show psychiatric, behavioural and motor disorders. Transgenic animal models are essential to the study of HD since the disease only affects humans. Therefore, the aim of this article was to describe the formation and maintenance of and to validate the progressive neurological phenotype of an R6/1 transgenic mouse colony. To achieve our objective, the colony founder was imported from Jackson Laboratories, and the mice were kept under controlled environmental conditions. The animals were bred at the vivarium of the Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. The R6/1 transgenic mice were successfully bred and showed genetic and phenotypic characteristics similar to the ones previously reported. Our colony is currently established and validated with the conditions of our vivarium and has produced more than four generations of R6/1 mice. The establishment of the R6/1 colony and its maintenance through generation is an advantage since it allows us to follow the authenticity of the transgenic mice regarding their phenotypic and motor behaviours. Furthermore, these animals can be compared with other transgenic mice that reproduce some of the main characteristics of the disease manifested in humans, making these transgenic R6/1 mice a useful tool for the study of HD.